Forcyte Biotechnologies, Inc. STTR Phase I Award, September 2021
A STTR Phase I contract was awarded to Forcyte Biotechnologies in September, 2021 for $350,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
350,000
1
Government Branch
Date Awarded
September 14, 2021
1
End Date
August 31, 2022
1
SBIR/STTR Award Recipient
Contract Number (US Government)
1R41GM146269-01
1
Award Phase
Phase I
1
Award Type
STTR
1
Official Website
Find more entities like Forcyte Biotechnologies, Inc. STTR Phase I Award, September 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.